Evidence map›Paper›PMID 34655420›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2022

Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of Oncology.

Nicholas Pavlidis, Fedro A Peccatori, Matti Aapro, Alex Eniu, Elie Rassy, Franco Cavalli, Christian Rolfo, Alberto Costa

Erratum issuedAbstract read
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian Regions.Journal of cancer education : the official journal of the American Association for Cancer Education · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Nicholas PavlidisUniversity of Ioannina, Ioannina, Greece. npavlid@uoi.gr.ORCID 0000-0002-2195-9961
Fedro A PeccatoriEuropean School of Oncology College (ESCO), Milan, Italy.
Matti AaproEuropean School of Oncology College (ESCO), Milan, Italy.
Alex EniuEuropean School of Oncology College (ESCO), Milan, Italy.
Elie RassyDépartement de Médecine Oncologique, Gustave Roussy, F-94805, Villejuif, France.
Franco CavalliEuropean School of Oncology College (ESCO), Milan, Italy.
Christian RolfoUniversity of Maryland and Stewart Greenebaum Comprehensive Cancer Centre, Baltimore, USA.
Alberto CostaEuropean School of Oncology College (ESCO), Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Certificate of Competence and Advanced Studies Program is an academically recognized postgraduate program that is organized by the European School of Oncology in collaboration with the University of Ulm and the University of Zurich. It is a part-time educational activity that aims to provide physicians and scientists with advanced knowledge in the management of patients with breast cancer, lymphoma, and lung cancer. The program encloses three attendance seminars and four to five e-learning modules that extend over 12 to 14 months. To be certified, participants have to pass an online test after each module followed by a final certification exam at the end of the program. This article reports on the 8-year experience of the 166 graduated fellows who have attended the program.

Indexed as

CertificationClinical CompetenceMedical OncologyPhysiciansCurriculumEuropeHumansSchoolsBreast cancer programCertificate of Competence and Advanced Studies ProgramEuropean School of OncologyLung cancer programLymphoma program

Identifiers

PMID34655420
PMCPMC8520329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.